Can fibromyalgia or CFS cause mood problems, like depression or anxiety? 

Living with a long-term condition such as fibromyalgia or chronic fatigue syndrome (ME/CFS) often involves more than just physical symptoms. It is very common for individuals with these conditions to experience significant changes in their mood, including feelings of depression and anxiety. These emotional challenges are frequently a direct response to the profound impact that chronic pain and exhaustion have on a person’s daily life, including their ability to work, socialise, and maintain their independence. In the UK, the NHS and NICE recognise that emotional well-being is an essential part of managing these conditions, as the physical and mental aspects of health are closely linked. 

What We’ll Discuss in This Article 

• The bidirectional link between chronic illness and emotional health 

• Understanding the risk of depression in fibromyalgia patients 

• Why anxiety is frequently associated with ME/CFS 

• The role of the central nervous system in regulating mood and pain 

• How lifestyle changes and disability can impact mental wellbeing 

• UK-based support options and recommended talking therapies 

The relationship between chronic illness and mood 

The connection between physical illness and mental health is well-documented within the UK healthcare system. When a person is diagnosed with a condition like fibromyalgia or ME/CFS, they are not just dealing with pain or fatigue; they are also navigating a significant life change. The limitations imposed by these conditions can lead to a sense of loss, frustration, and uncertainty about the future. For many, the transition from being active and independent to having a disabling long-term illness is a major stressor that naturally affects mood and emotional stability. 

It is important to clarify that having mood problems does not mean that fibromyalgia or ME/CFS are psychological illnesses. According to the NICE guidelines for ME/CFS, the condition is a complex biological disorder. However, the guidelines also acknowledge that the burden of living with such a debilitating illness can lead to secondary mental health challenges. Similarly, the NHS describes fibromyalgia as a physical pain syndrome that can be triggered or worsened by emotional stress, creating a complex cycle where physical symptoms and mood problems feed into each other. 

Research indicates that people with chronic physical health conditions are significantly more likely to experience a common mental health condition than those without. This is often because the daily struggle to manage symptoms, attend medical appointments, and cope with the “invisible” nature of the illness can be emotionally exhausting. Recognising this link is a vital part of the diagnostic and management process in the UK, as treating the emotional impact can often help make the physical symptoms more manageable. 

Depression and the impact of fibromyalgia 

Depression is one of the most common co-existing conditions for those with fibromyalgia. It is estimated that between 30% and 50% of people with the syndrome also experience symptoms of depression at some point. This relationship is often described as bidirectional. This means that while the pain and isolation of fibromyalgia can lead to depression, the presence of depression can also lower a person’s pain tolerance and make the physical symptoms feel more intense. 

In the UK, the NHS identifies low mood and depression as potential symptoms or complications of fibromyalgia. Patients may feel constantly low, lose interest in activities they once enjoyed, and feel hopeless about their recovery. These feelings are often compounded by the poor sleep quality and “fibro-fog” that are also part of the condition. When a person is permanently exhausted and in pain, it is biologically difficult for the brain to maintain a positive emotional state. 

The biological link between the two may also involve neurotransmitters, which are chemicals in the brain that send signals. Chemicals such as serotonin and norepinephrine play a dual role: they help regulate mood and they help dampen down pain signals in the spinal cord. In fibromyalgia, these chemicals may be imbalanced, which provides a physical explanation for why low mood and increased pain sensitivity often appear together. This is why certain medications, such as antidepressants, are sometimes prescribed for fibromyalgia even when depression is not the primary diagnosis. 

Anxiety and the unpredictability of ME/CFS 

Anxiety is another frequent companion for those living with ME/CFS. This is often driven by the unpredictable nature of the condition. Because symptoms can fluctuate from day to day, patients may develop “anticipatory anxiety,” where they constantly worry about when the next “crash” or period of post-exertional malaise (PEM) will occur. This can lead to a state of hyper-vigilance, where the individual is always monitoring their body for early signs of exhaustion, which itself can be a source of significant stress. 

The limitations on physical activity can also cause social anxiety. Patients may worry about letting friends down or being unable to participate in family events. Over time, this can lead to social withdrawal and isolation, which further fuels the anxiety. For younger people, the anxiety may be focused on falling behind in school or missing out on key developmental milestones with their peers. In the UK, the impact of ME/CFS on a young person’s mental health is a priority area for specialist paediatric services. 

Physical symptoms of ME/CFS, such as heart palpitations, dizziness, and shortness of breath, can also mimic the physical signs of an anxiety attack. This can be confusing for patients and may lead to a cycle where the physical symptoms of the illness trigger an anxious response, which then makes the physical symptoms worse. Distinguishing between the biological symptoms of the condition and the emotional response to them is an important part of the management strategy discussed in specialist ME/CFS clinics. 

Breaking the cycle of pain and low mood 

The primary goal of managing mood problems alongside chronic illness is to break the cycle of “pain-stress-pain.” When a person is stressed, anxious, or depressed, their body’s stress-response system is constantly activated. This leads to increased muscle tension and the release of hormones like cortisol, which can make the nervous system even more sensitive to pain. By addressing the emotional health of the patient, clinicians aim to calm the nervous system and reduce the overall burden of symptoms. 

In the UK, this is often achieved through a multidisciplinary approach. This might involve a GP, a physiotherapist, and a psychologist working together. The focus is on providing the patient with a toolkit of coping strategies. These can include relaxation techniques, mindfulness, and gentle activity management. The aim is to help the person regain a sense of control over their life, which is one of the most effective ways to combat feelings of helplessness and depression. 

It is also vital to address sleep hygiene, as poor sleep is a major contributor to both pain and low mood. In both fibromyalgia and ME/CFS, improving the quality of whatever sleep is possible can provide the brain with the restorative rest it needs to regulate emotions more effectively. The NHS encourages patients to see emotional health as a valid part of their physical care plan, rather than something that is secondary or “just in their head.” 

UK-based support and talking therapies 

For those experiencing mood problems as a result of their condition, the NHS offers several types of talking therapies. Cognitive Behavioural Therapy (CBT) is one of the most frequently recommended. In the context of chronic illness, CBT is not used to suggest that the illness is psychological. Instead, it helps patients identify the links between their thoughts, feelings, and behaviours. For example, it can help a patient change the way they think about a flare-up, reducing the fear and distress that can make the symptoms feel worse. 

Acceptance and Commitment Therapy (ACT) is another evidence-based approach used in the UK for long-term pain management. ACT focuses on helping patients accept the things they cannot change, such as the presence of a chronic illness, while committing to activities that align with their values. This can be particularly helpful for those struggling with the loss of their previous identity or lifestyle. These therapies are often delivered through NHS Talking Therapies services, which can be accessed via a GP referral or, in some areas, through self-referral. 

Support groups also play a massive role in the UK. Talking to others who are going through the same experience can reduce the sense of isolation and provide practical tips for daily living. Charities such as Fibromyalgia Action UK and the ME Association provide networks of local groups and online forums where patients can find validation and community support. Knowing that you are not alone in your struggle can be a powerful antidote to the low mood and anxiety that often accompany these conditions. 

Conclusion 

Mood problems such as depression and anxiety are very common in people with fibromyalgia and ME/CFS, often arising as a direct consequence of the life-altering impact of these conditions. The relationship is complex and bidirectional, involving both biological changes in the brain and the emotional stress of living with a chronic, often invisible, disability. Recognising and treating these mood symptoms through talking therapies, medication, and supportive care is an essential part of the NHS management plan. By addressing both the mind and the body, patients can improve their overall wellbeing and find more effective ways to live with their condition. 

If you experience severe, sudden, or worsening symptoms, or if you feel you may harm yourself, call 999 immediately. 

Authority Snapshot (E-E-A-T Block) 

This article explores the connection between chronic illness and mood problems within the UK healthcare framework. It was prepared by the MyPatientAdvice team and reviewed by Dr. Stefan Petrov to ensure the content is medically accurate and aligns with the latest NHS and NICE clinical guidance. The purpose of this information is to support patient education and encourage a holistic approach to managing long-term conditions.